{"version":"1.0","type":"link","title":"Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B41 Clinical Trial Validation.","author_name":"Bharadwaj S 외","author_url":"https://prs-insight.online/author/Bharadwaj%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79368","thumbnail_width":1200,"thumbnail_height":630}